title: Iron as catalyst for oxidative stress in the pathogenesis of Parkinson's disease?
abstract: The mechanisms leading to degeneration of melanized dopaminergic neurons in the brain stem, and particularly in the substantia nigra zona compacta (SNZC) in patients with Parkinson's disease (PD) are still unknown. Demonstration of increased iron Fe(III) in SNZC of PD brain has suggested that Fe-melanin interaction may contribute to oxidative neuronal damage. Energy dispersive X-ray electron microscopic analysis of the cellular distribution of trace elements revealed significant Fe-peaks, similar to those of a synthetic melanin-Fe(III) complex in intracytoplasmic electron-dense neuromelanin granules of SNZC neurons, with highest levels in a case of PD and Alzheimer's disease (AD). No Fe increase was found in Lewy bodies or in SN neurons of control specimens. The relevance of chemical reactions of dopamine (DA), 5-hydroxydopamine (5-OHDA), and 6-hydroxydopamine (6-OHDA) with Fe(III) and with dioxygen for the pathogenesis of PD was investigated. An initiating mechanism related to interaction between Fe and neuromelanin is suggested which results in accumulation of Fe(III) and a continuous production of cytotoxic species inducing a cascade of pathogenic reactions ultimately leading to neuronal death.
authors.affiliation: Ludwig Boltzmann Institute of Clinical Neurobiology, PKH, Vienna, Austria.
authors.forename: E
authors.initials: E
authors.lastname: Kienzl
authors.forename: K
authors.initials: K
authors.lastname: Jellinger
authors.forename: H
authors.initials: H
authors.lastname: Stachelberger
authors.forename: W
authors.initials: W
authors.lastname: Linert
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001921:Brain / Q000378:metabolism / Q000473:pathology; D002384:Catalysis; D004298:Dopamine / Q000737:chemistry / Q000378:metabolism; D004577:Electron Probe Microanalysis; D006801:Humans; D006892:Hydroxydopamines / Q000737:chemistry / Q000378:metabolism; D066298:In Vitro Techniques; D007501:Iron / Q000737:chemistry / Q000502:physiology*; D007700:Kinetics; D016631:Lewy Bodies / Q000378:metabolism / Q000473:pathology; D018384:Oxidative Stress / Q000502:physiology*; D016627:Oxidopamine / Q000737:chemistry / Q000378:metabolism; D010300:Parkinson Disease / Q000473:pathology / Q000503:physiopathology*; D014227:Triazines / Q000378:metabolism
chemical_list: D006892:Hydroxydopamines; D014227:Triazines; C027802:5-hydroxydopamine; D016627:Oxidopamine; D007501:Iron; C011907:melamine; D004298:Dopamine